Pharma companies on standby for flu jabs

Toronto News.Net
Sunday 28th June, 2009

GlaxoSmithKline and Roche, two major pharmaceutical companies, have had sizeable sales increases during the first quarter of 2009.

A lot of the money has come from people wishing to protect themselves from the swine flu epidemic.

Driven in part by the outbreak of avian flu in 2006, countries have been releasing treatments of anti-virals which can also be used to fight swine flu, officially known as the H1N1 virus.

Relenza and Tamiflu sales have already increased profits massively for Relenza and Roche.

Email this story to a friend

Have your say on this story

Top Stories

Indian-origin ex-MP's acquittal for cocaine sparks outrage in Canada
An Indian-origin former MP in Canada is in the eye of a political storm after his acquittal by a court on cocaine possession and drunken driving charges. [read story]
Hungry people unable to get through corruption for UN food
A United Nations report, which is still to be released, has found that up to half the food aid in Somalia is diverted to corrupt contractors, local UN workers and Islamic militants. [read story]
Threat on Internet leads to school lockdowns
A number of schools in the US were closed down on Wednesday after posted on a social networking site. [read story]
Officials take whale meat of restaurant menu
Federal prosecutors in the US have charged the owner of a California restaurant over alleged sales of whale meat, which was labelled sushi. [read story]
Iranian president denigrates US presence in Afghanistan
With official visits overlapping in Afghanistan, Iran's outspoken president and the US defence secretary have accused each other of interfering in local affairs. [read story]